2,249
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Can we achieve affordable cancer medicine prices? Developing a pathway for change

Pages 321-325 | Received 13 Jan 2021, Accepted 02 Mar 2021, Published online: 12 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sabine Vogler, Maximilian Salcher-Konrad & Katharina Habimana. (2023) Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 867-878.
Read now
Julian Perelman, Filipa Duarte-Ramos, António Melo Gouveia, Luis Pinheiro, Francisco Ramos, Sabine Vogler & Céu Mateus. (2023) How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021. Expert Review of Pharmacoeconomics & Outcomes Research 23:1, pages 99-109.
Read now
Fei Yuan, Shrikant I. Bangdiwala, Wesley Tong & Andre Lamy. (2023) The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices. Expert Review of Pharmacoeconomics & Outcomes Research 23:1, pages 69-78.
Read now

Articles from other publishers (5)

P. Le Coz & G. Bouvenot. (2023) Éthique et médicament : faut-il s’indigner du prix de certains médicaments ?. Bulletin de l'Académie Nationale de Médecine.
Crossref
Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova & Brian Godman. (2022) Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries. Frontiers in Pharmacology 13.
Crossref
Gyeongseon Shin, Hye-Young Kwon & SeungJin Bae. (2022) For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs. International Journal of Environmental Research and Public Health 19:7, pages 4204.
Crossref
Wolf-Dieter Ludwig & Bernd Mühlbauer. 2022. Arzneiverordnungs-Report 2022. Arzneiverordnungs-Report 2022 3 27 .
Wolf-Dieter Ludwig & Bernd Mühlbauer. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021 3 35 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.